NCNA NuCana plc

NASDAQ
$1.28

NuCana plc (NCNA) is expected to report earnings on November 12, 2026, after the market close.

NuCana plc Reported Earnings
Thursday, August 13, 2026 · 4:01 PM ET
Earnings Date
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NuCana plc

NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company's pipeline of products includes Acelarin, NUC-3373 and NUC-7738 which are in clinical stage. NuCana PLC is based in EDINBURGH, United Kingdom.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.